Promoter-specific activation defects by a novel yeast TBP mutant compromised for TFIIB interaction

TFIIB is an RNA polymerase II general transcription factor (GTF) that has also been implicated in the mechanism of action of certain promoter-specific activators (see, for examples, [1-11]). TFIIB enters the preinitiation complex (PIC) primarily through contact with the TATA box binding protein (TBP), an interaction mediated by three TBP residues [12-14]. To study the role of TFIIB in transcription activation in vivo, we randomly mutagenized these three residues in yeast TBP and screened for promoter-specific activation mutants. One mutant bearing a single conservative substitution, TBP-E186D, is the focus of this study. As expected, TBP-E186D binds normally to the TATA box but fails to support the entry of TFIIB into the PIC. Cells expressing TBP-E186D are viable but have a severe slow-growth phenotype. Whole-genome expression analysis indicates that transcription of 17% of yeast genes are compromised by this mutation. Chimeric promoter analysis indicates that the region of the gene that confers sensitivity to the TBP-E186D mutation is the UAS (upstream activating sequence), which contains the activator binding sites. Most interestingly, other TBP mutants that interfere with different interactions (TFIIB, TFIIA, or the TATA box) and a TFIIB mutant defective for interaction with TBP all manifest distinct and selective promoter-specific activation defects. Our results implicate the entry of TFIIB into the PIC as a critical step in the activation of certain promoters and reveal diverse mechanisms of transcription activation.

[1]  B. O’Malley,et al.  Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). , 1992, The Journal of biological chemistry.

[2]  D. Reinberg,et al.  Protein-protein interactions in eukaryotic transcription initiation: structure of the preinitiation complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Michael R. Green,et al.  A role for activator-mediated TFIIB recruitment in diverse aspects of transcriptional regulation , 1995, Current Biology.

[4]  Michael R. Green,et al.  Enhancement of TBP binding by activators and general transcription factors , 1999, Nature.

[5]  K. Struhl,et al.  A severely defective TATA-binding protein-TFIIB interaction does not preclude transcriptional activation in vivo , 1997, Molecular and cellular biology.

[6]  Michael R. Green,et al.  Dissecting the Regulatory Circuitry of a Eukaryotic Genome , 1998, Cell.

[7]  F. Holstege,et al.  Broad, but not universal, transcriptional requirement for yTAFII17, a histone H3-like TAFII present in TFIID and SAGA. , 1998, Molecular cell.

[8]  Michael R. Green,et al.  Mechanism of action of an acidic transcriptional activator in vitro , 1991, Cell.

[9]  R. Roeder,et al.  Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Struhl,et al.  Transcriptional activation in yeast cells lacking transcription factor IIA. , 1999, Genetics.

[11]  R. Wood,et al.  Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours , 1999, Current Biology.

[12]  J. Manley,et al.  Interaction between a transcriptional activator and transcription factor IIB in vivo , 1993, Nature.

[13]  S. Burley,et al.  Crystal structure of a TFIIB–TBP–TATA-element ternary complex , 1995, Nature.

[14]  K. Struhl,et al.  Mutations on the DNA-binding surface of TATA-binding protein can specifically impair the response to acidic activators in vivo , 1995, Molecular and cellular biology.

[15]  Michael R. Green,et al.  Activator-induced conformational change in general transcription factor TFIIB , 1994, Nature.

[16]  S. Roberts,et al.  The conformation of the transcription factor TFIIB modulates the response to transcriptional activators in vivo , 2000, Current Biology.

[17]  A. Berk Activation of RNA polymerase II transcription. , 1999, Current opinion in cell biology.

[18]  F. Winston,et al.  TBP mutants defective in activated transcription in vivo. , 1995, The EMBO journal.

[19]  W. Herr,et al.  The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Burley,et al.  Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo. , 1996, Genes & development.

[21]  M. Hampsey,et al.  An activation-specific role for transcription factor TFIIB in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  U. Hansen,et al.  Activation of RNA polymerase II transcription by the specific DNA-binding protein LSF. Increased rate of binding of the basal promoter factor TFIIB. , 1992, The Journal of biological chemistry.

[23]  P. Lieberman,et al.  Association of Transcription Factor IIA with TATA Binding Protein Is Required for Transcriptional Activation of a Subset of Promoters and Cell Cycle Progression inSaccharomyces cerevisiae , 1998, Molecular and Cellular Biology.

[24]  Michael R. Green,et al.  Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation , 1993, Nature.

[25]  K. Struhl,et al.  The TBP-TFIIA interaction in the response to acidic activators in vivo. , 1995, Science.

[26]  Michael R. Green,et al.  Yeast TAFII145 Functions as a Core Promoter Selectivity Factor, Not a General Coactivator , 1997, Cell.

[27]  M Ikura,et al.  Human general transcription factor TFIIB: conformational variability and interaction with VP16 activation domain. , 1998, Biochemistry.

[28]  Kevin Struhl,et al.  Yeast and human TFIID with altered DNA-binding specificity for TATA elements , 1992, Cell.